Inhibition of Cytomegalovirus in vitro and in vivo by the Experimental Immunosuppressive Agent Leflunomide

Publisher： Karger

E-ISSN： 1423-0100|42|5-6|412-418

ISSN： 0300-5526

Source： Intervirology, Vol.42, Iss.5-6, 2000-02, pp. : 412-418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of the Tyrosine Phosphatase SHP-2 Suppresses Angiogenesis in vitro and in vivo

By  

Journal of Vascular Research, Vol. 45, Iss. 2, 2007-10 ,pp. : 153-163

Karger

Access to resources Recommend Favorite

Leflunomide

By  

PRACTICAL DIABETES (INCORPORATING CARDIABETES), Vol. 35, Iss. 1, 2018-01 ,pp. : 34-35

John Wiley & Sons Inc

Access to resources Recommend Favorite

A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease

By Poturoglu Sule   Kaymakoglu Sabahattin   Gurel Polat Nuray   Ibrisim Duygu   Ahishali Emel   Akyuz Filiz   Badur Selim   Demir Kadir   Mungan Zeynel  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 69, Iss. 6, 2009-10 ,pp. : 696-702

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 189-198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: A case series and review of the literature

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite